Lazertinib Nitroso Impurity 4 - Request Quote
Lazertinib Nitroso Impurity 4
| SZ CAT No: | SZ-L127017 |
| CAS No | NA |
| Mol.F. | C27H31N9O3 |
| Mol.Wt. | 529.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lazertinib Nitroso Impurity 4 is chemically N-(5-amino-2-methoxy-4-morpholinophenyl)-N-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)nitrous amide. Lazertinib Nitroso Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Lazertinib Nitroso Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lazertinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Lazertinib Nitroso Impurity 4
Purchase Lazertinib Nitroso Impurity 4
Lazertinib Nitroso Impurity 4 suppliers
Lazertinib Nitroso Impurity 4 manufacturers
Lazertinib Nitroso Impurity 4 price
Order Lazertinib Nitroso Impurity 4
Enquire Lazertinib Nitroso Impurity 4
Lazertinib Nitroso Impurity 4 cost
Lazertinib Nitroso Impurity 4 Supplier
Lazertinib Nitroso Impurity 4 Distributor
Lazertinib Nitroso Impurity 4 for Method Validation
Lazertinib Reference Standard
Lazertinib Nitroso Impurity 4 for ANDA Filing
Lazertinib Nitroso Impurity 4 for Forced Degradation Studies
Lazertinib Nitroso Impurity 4 Identification Standards
Lazertinib Nitroso Impurity 4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.